Use of a protein and its encoding gene in regulating bacterial spot resistance of plants

By introducing the AopP2 protein and its encoding gene into plants, and utilizing recombinant vectors and microbial technology, the plant's resistance to bacterial fruit spot disease was enhanced, solving the problem of controlling bacterial fruit spot disease in existing technologies and achieving improved disease resistance and antibacterial activity.

CN119431534BActive Publication Date: 2026-11-10GUANGXI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411451586.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-10-17
Publication Date
2026-11-10
Estimated Expiration
2044-10-17

AI Technical Summary

Technical Problem

There is a lack of effective control measures for bacterial fruit spot disease in the current technology, especially for watermelon and melon diseases that are transmitted through seeds, which leads to serious production losses. Furthermore, no commercially available varieties or targeted agents that are immune or highly resistant have been found.

Method used

By introducing the AopP2 protein and its encoding gene, the disease resistance and antibacterial properties of plants can be regulated. The AopP2 protein can be expressed in plants using recombinant vectors and recombinant microorganisms to enhance the plant's resistance to bacterial fruit spot disease.

Benefits of technology

It improved the disease resistance and antibacterial properties of plants, achieving broad-spectrum and long-lasting resistance to bacterial fruit spot disease, and promoted the breeding of disease-resistant plants.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119431534B_ABST
    Figure CN119431534B_ABST
Patent Text Reader

Abstract

The application discloses a protein and application of a coding gene thereof in regulating bacterial fruit spot resistance of plants. The protein provided by the application is named as AopP2 protein, and is a protein as shown in SEQ ID NO:1. A nucleic acid molecule coding the AopP2 protein also belongs to the protection range of the application. The application also protects application of the AopP2 protein or the nucleic acid molecule coding the AopP2 protein in regulating disease resistance and / or bacterial resistance of plants. The inventor of the application first explains the function of the effector protein AopP2 in the plant interaction process, and the AopP2 protein is an effector protein with elicitor activity, and the plant disease resistance can be improved by using the AopP2 protein. The application has important significance for realizing fruit spot resistant plant breeding and improving the broad-spectrum and persistent disease resistance of the plant against the fruit spot.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biotechnology and relates to the application of a protein and its encoding gene in the positive regulation of plant resistance to bacterial fruit spot disease. Background Technology

[0002] Bacterial fruit blotch (BFB) is a bacterial disease caused by Paracidovoraxcitrulli (Pc), which affects cucurbit crops worldwide. It mainly damages the fruits of watermelons and melons, while also affecting their leaves, causing lesions and fruit rot, leading to reduced yield and lower commercial value.

[0003] The pathogens causing bacterial fruit spot disease are mainly transmitted through seeds. The pathogens are then transmitted to seedlings through infected seeds, causing seedling disease. Once the disease occurs, it is very difficult to control, posing a huge threat to crop production.

[0004] In terms of disease control, measures such as seed treatment, seed quarantine, and chemical control have limited effectiveness against bacterial fruit spot disease. To date, no commercially available varieties of watermelon or melon that are immune or highly resistant have been found, and there is a lack of targeted control agents. Controlling bacterial fruit spot disease has become an urgent problem to be solved. Therefore, the genetic analysis and localization of bacterial fruit spot resistance genes and their application in breeding disease-resistant plants is urgently needed. Summary of the Invention

[0005] The purpose of this invention is to provide an application of a protein and its encoding gene in regulating plant resistance to bacterial fruit spot disease.

[0006] The protein provided by this invention is named AopP2 protein, and is as follows (a1) or (a2) or (a3) ​​or (a4) or (a5) or (a6):

[0007] (a1) The protein shown in SEQ ID NO: 1;

[0008] (a2) A fusion protein having the protein described in (a1);

[0009] (a3) A protein related to plant disease resistance obtained by substituting and / or deleting and / or adding one or more amino acid residues of the protein described in (a1);

[0010] (a4) is a protein that has more than 98% identity with the protein described in (a1) and is associated with plant disease resistance;

[0011] (a5) A protein related to plant antibacterial activity obtained by substituting and / or deleting and / or adding one or more amino acid residues of the protein described in (a1).

[0012] (a6) is a protein that has more than 98% identity with the protein described in (a1) and is associated with plant antibacterial properties.

[0013] Specifically, the fusion protein described in (a2) may be a fusion protein obtained by attaching a tag to the N-terminus and / or C-terminus of the protein described in (a1).

[0014] Nucleic acid molecules encoding the AopP2 protein are also within the scope of protection of this invention.

[0015] The nucleic acid molecule can be either a DNA molecule or an RNA molecule.

[0016] Specifically, the nucleic acid molecule is as follows (b1) or (b2) or (b3):

[0017] (b1) Nucleic acid molecules whose coding region is shown as positions 1 to 1515 in SEQ ID NO: 2;

[0018] (b2) A nucleic acid molecule that has more than 95% identity with (b1) and encodes the protein;

[0019] (b3) A nucleic acid molecule that hybridizes with the nucleic acid molecule defined in (b1) under strict conditions and encodes the protein thereon.

[0020] The above stringent conditions can be achieved by hybridization at 65°C and washing the membrane in a solution of 0.1×SSPE (or 0.1×SSC) and 0.1% SDS during DNA or RNA hybridization experiments.

[0021] The nucleic acid molecule may be the AopP2 gene.

[0022] Specifically, the AopP2 gene can be a DNA molecule with a coding region as shown in positions 1 to 1515 of SEQ ID NO: 2.

[0023] Specifically, the AopP2 gene may be a DNA molecule with a coding region as shown in SEQ ID NO: 2.

[0024] Expression cassettes, recombinant vectors, recombinant microorganisms, or transgenic plant cells containing the aforementioned nucleic acid molecules are all within the scope of protection of this invention.

[0025] Specifically, the recombinant vector containing the nucleic acid molecule is obtained by replacing the DNA fragments containing the CmR gene and ccdB gene from attR1 to attR2 in the vector pCPP5371 with a DNA fragment containing a foreign DNA molecule (as shown in nucleotides 1-1515 of SEQ ID NO: 2). Specifically, the preparation method of the recombinant vector containing the nucleic acid molecule is as follows: using the double-stranded DNA molecule shown in SEQ ID NO: 2 as a template, PCR amplification is performed using a primer pair composed of aopP2-attB1 and aopP2-attB2 to obtain the PCR amplification product. The PCR amplification product is compared with Gateway. TM pDONR TM Vector 221 was recombined with BP to obtain an intermediate vector. The intermediate vector was then recombined with vector pCPP5371 with LR to obtain the recombinant plasmid pCPP5371-AopP2.

[0026] Specifically, the recombinant microorganism containing the aforementioned nucleic acid molecule is a recombinant bacterium obtained by introducing a recombinant vector containing the aforementioned nucleic acid molecule into *Pseudomonas fluorescens* EtHAn. Specifically, the preparation method of the recombinant microorganism containing the aforementioned nucleic acid molecule is as follows: AopP2 gene donor bacteria, pRK600 plasmid donor bacteria, and *Pseudomonas fluorescens* EtHAn are co-cultured to obtain recombinant *Pseudomonas fluorescens* containing the aforementioned nucleic acid molecule. The recombinant plasmid pCPP5371-AopP2 is introduced into *Escherichia coli* DH5α competent cells to obtain recombinant *Escherichia coli*, which is the AopP2 gene donor bacteria. The pRK600 plasmid is introduced into *Escherichia coli* DH5α competent cells to obtain recombinant *Escherichia coli*, which is the pRK600 plasmid donor bacteria.

[0027] This invention also protects the use of the AopP2 protein or nucleic acid molecules encoding the AopP2 protein in the positive regulation of disease resistance and / or antibacterial activity in plants.

[0028] Positive regulation means that an increase in AopP2 protein content leads to increased disease resistance and / or antibacterial activity in plants.

[0029] Positive regulation means that an increase in the content of nucleic acid molecules encoding the AopP2 protein leads to increased disease resistance and / or antibacterial activity in plants.

[0030] The present invention also protects the application of biological materials, as follows (c1) or (c2) or (c3):

[0031] (c1) Application in the preparation of products for improving the disease resistance and / or antibacterial properties of plants;

[0032] (c2) Application in plant breeding; the goal of the plant breeding is to obtain plant germplasm with improved disease resistance and / or antibacterial properties;

[0033] (c3) Application in the preparation of antibacterial agents.

[0034] The present invention also provides a product containing biological materials;

[0035] The functions of the product are as follows (d1) or (d2) or (d3):

[0036] (d1) Enhance the disease resistance and / or antibacterial properties of plants;

[0037] (d2) Plant breeding; the goal of the plant breeding is to obtain plant germplasm with improved disease resistance and / or antibacterial properties;

[0038] (d3) Antibacterial agent.

[0039] The biological material described above may be AopP2 protein, nucleic acid molecule encoding AopP2 protein, expression cassette containing nucleic acid molecule encoding AopP2 protein, recombinant vector containing nucleic acid molecule encoding AopP2 protein, or recombinant microorganism containing nucleic acid molecule encoding AopP2 protein.

[0040] This invention also provides a method for cultivating plants with enhanced disease resistance and / or antibacterial activity, comprising the following steps: introducing a nucleic acid molecule encoding the AopP2 protein into a recipient plant to obtain a plant with enhanced disease resistance and / or antibacterial activity. Specifically, in the method, a recombinant vector containing the nucleic acid molecule or a recombinant microorganism containing the nucleic acid molecule is introduced into the recipient plant.

[0041] The present invention also provides a method for cultivating plants with enhanced disease resistance and / or antibacterial properties, comprising the following steps: increasing the content of AopP2 protein in the plant to obtain plants with enhanced disease resistance and / or antibacterial properties.

[0042] This invention also protects the application of any of the methods described above in plant breeding. The goal of the plant breeding is to obtain plant germplasm with enhanced disease resistance and / or antibacterial properties.

[0043] Specifically, the disease resistance refers to resistance to fruit spot disease.

[0044] Specifically, the disease resistance refers to resistance to bacterial fruit spot disease.

[0045] Specifically, the bacterial fruit spot disease refers to bacterial fruit spot disease of cucurbits.

[0046] Specifically, the melons mentioned are watermelons and / or cantaloupes.

[0047] Specifically, the bacterial fruit spot disease is caused by *Ligustrum lucidum*.

[0048] Specifically, the antibacterial property refers to resistance to acid-eating bacteria.

[0049] Specifically, the antibacterial property refers to resistance to citrus acidophilus.

[0050] Specifically, the plant is a dicotyledonous plant or a monocotyledonous plant.

[0051] Specifically, the plant in question belongs to the Cucurbitales order.

[0052] Specifically, the plant in question is a member of the Cucurbitaceae family.

[0053] Specifically, the plant in question is a member of the genus *Citrus*.

[0054] Specifically, the plant in question is a watermelon, such as the Jingxin No. 4 watermelon.

[0055] Pretreatment of plants (e.g., watermelon leaves) with the aforementioned biological material triggers an ETI response (ETI response: an immune response triggered by effector factors), thereby enhancing the plant's disease resistance.

[0056] The inventors of this invention have, for the first time, elucidated the function of the effector protein AopP2 in its interaction with plants. AopP2 is an effector protein with elicitor activity, which can be used to enhance plant disease resistance. This invention is of great significance for breeding plants resistant to fruit spot disease and improving the broad-spectrum and long-lasting resistance of plants to this disease. Attached Figure Description

[0057] Figure 1 For Gateway TM pDONR TM Vector map of vector 221.

[0058] Figure 2 The vector map is for the pCPP5371 vector.

[0059] Figure 3 This is an exemplary photograph of the leaf taken in step two of Example 2.

[0060] Figure 4 The result is the ROS detection result in step two of Example 2.

[0061] Figure 5 This is the result of statistical conductivity in step two of Example 2.

[0062] Figure 6 This is a photograph of the Western bolt result from Example 3.

[0063] Figure 7 This is an exemplary photograph of the leaf taken in step three of Example 4.

[0064] Figure 8This is the statistical result of the number of pathogenic bacteria colonies in step three of Example 4. Detailed Implementation

[0065] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.

[0066] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available. Unless otherwise specified, all quantitative experiments in the following examples were performed in triplicate, and the results were averaged. *E. coli* DH5α competent cells: a product of Shanghai Tolo Biotech, catalog number CC96102. TM pDONR TM 221 Vector: Invitrogen product. The effector protein discovered in this invention is the AopP2 protein, as shown in SEQ ID NO: 1. The gene encoding the AopP2 protein is named the AopP2 gene, and its open reading frame is shown in SEQ ID NO: 2.

[0067] The composition of each liter of liquid KB medium (pH 7.2) is: 20g peptone, 15mL glycerol, 1.5g K₂HPO₄, 1.5g MgSO₄·7H₂O, with the remainder being water. The only difference between the liquid and solid KB medium is the addition of 15g agar.

[0068] The vector pCPP5371 is described in the following literature: Supramolecular Structure and Functional Analysis of the Type III Secretion System in Pseudomonas fluorescens 2P24; Frontiers in Plant Science (www.frontiersin.org), January 2016, Volume 6, Article 1190; doi:10.3389 / fpls.2015.01190. The vector pCPP5371 contains a gentamicin resistance gene.

[0069] The fluorescens bacterium EtHAn (Pseudomonas fluorescens EtHAn) is described in the following literature: A Acterial Type Three Secretion-Based Delivery System for Functional Characterization of Sporisorium scitamineum Plant Immune Suppressing Effector Proteins; Molecular and Physiological Plant Pathology; DOI:10.1094 / PHYTO-08-21-0326-R.

[0070] The pRK600 plasmid is described in the following literature: Involvement of hrpX and hrpG in the Virulence of Acidovorax citrulli Strain Aac5, Causal Agent of Bacterial Fruit Blotch in Cucurbits; Frontiers in Microbiology, March 2018, Volume 9, Article 507; doi:10.3389 / fmicb.2018.00507.

[0071] The pBBR1MCS-2 plasmid is described in the following literature: Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes; Gene, 166(1995)175-176; DOI:10.1016 / 0378-1119(95)00584-1. The pBBR1MCS-2 plasmid contains a kanamycin resistance gene.

[0072] Example 1: Preparation of recombinant bacteria

[0073] I. Construction of recombinant plasmids

[0074] Using the double-stranded DNA molecule shown in SEQ ID NO: 2 as a template, PCR amplification was performed using a primer pair composed of aopP2-attB1 and aopP2-attB2 to obtain the PCR amplification product. The PCR amplification product was compared with Gateway. TM pDONR TM221 vector (see vector map) Figure 1 BP recombination was performed to obtain the intermediate vector. The intermediate vector and the vector pCPP5371 (vector pattern shown in...) Figure 2 LR recombination was performed to obtain the recombinant plasmid pCPP5371-AopP2. Compared with the vector pCPP5371, the only difference of the recombinant plasmid pCPP5371-AopP2 is that the DNA fragment containing the CmR gene and ccdB gene from attR1 to attR2 in the vector was replaced with a DNA fragment containing a foreign DNA molecule (as shown in nucleotides 1-1515 in SEQ ID NO: 2).

[0075] aopP2-attB1:ggggacaagtttgtacaaaaaagcaggctATGCCCCGTTCCGTCA;

[0076] aopP2-attB2:ggggaccactttgtacaagaaagctgggtATGCCTGTACCAGTCGCG.

[0077] II. Preparation of recombinant bacteria EtHAn-AopP2 by triparental hybridization.

[0078] 1. The recombinant plasmid pCPP5371-AopP2 was introduced into Escherichia coli DH5α competent cells to obtain recombinant E. coli, which is the AopP2 gene donor. The pRK600 plasmid was introduced into E. coli DH5α competent cells to obtain recombinant E. coli, which is the pRK600 plasmid donor.

[0079] 2. The AopP2 gene donor bacteria, pRK600 plasmid donor bacteria and fluorescent Pseudomonas EtHAn were mixed and inoculated into LB medium plates at pH 7.4 and co-cultured at 28°C for 8 hours. Then, the bacterial cells on the plates were collected with sterile water to obtain the bacterial solution.

[0080] 3. Inoculate the bacterial culture obtained in step 2 onto KB medium plates containing 100 μg / mL ampicillin and 50 μg / mL gentamicin, and incubate at 28°C for 48 h.

[0081] 4. After completing step 3, pick single clones from the plate for PCR identification. Select fluorescent Pseudomonas bacteria that are positive for PCR identification, which are the recombinant bacteria EtHAn-AopP2.

[0082] PCR identification method: Genomic DNA is extracted and PCR amplification is performed using primer pairs consisting of aopP2-JC-F (CCTCAATGCGGAGGACCCG) and aopP2-JC-R (cagcgcgaagatcctgcagg). If an amplification product of approximately 385 bp is obtained, the identification result is positive.

[0083] III. Preparation of recombinant bacteria EtHAn-EV.

[0084] By replacing the recombinant plasmid pCPP5371-AopP2 with the vector pCPP5371 and following the procedure in step two, the recombinant bacteria EtHAn-EV was obtained.

[0085] Example 2: Functional Verification of AopP2 Protein

[0086] I. Preparation of bacterial culture

[0087] The recombinant strain EtHAn-AopP2 was inoculated into liquid KB medium containing 100 μg / mL ampicillin and 50 μg / mL gentamicin, and cultured at 28°C with shaking at 200 rpm until OD. 600nm The value was 2.0, and then 10 mmol / L MgCl2 aqueous solution was added until the system OD was 2.0. 600nm A value of 0.5 indicates that the bacterial culture is EtHAn-AopP2.

[0088] The recombinant strain EtHAn-EV was inoculated into liquid KB medium containing 100 μg / mL ampicillin and 50 μg / mL gentamicin, and cultured at 28°C with shaking at 200 rpm until OD. 600nm The value was 2.0, and then 10 mmol / L MgCl2 aqueous solution was added until the system OD was 2.0. 600nm A value of 0.5 indicates that the bacterial culture is EtHAn-EV.

[0089] II. Functional Verification of AopP2 Protein

[0090] Test bacterial suspension: bacterial suspension EtHAn-AopP2 or bacterial suspension EtHAn-EV prepared in step one.

[0091] Watermelon seedlings of the Jingxin No. 4 variety were cultured normally until they had only two cotyledons, and then inoculated with the test bacterial solution. Inoculation method: Each cotyledon was injected separately, one on each side of the main vein, until the leaf was completely filled with the test bacterial solution. Then, normal culture was continued.

[0092] 1. Phenotypic observation

[0093] The timer starts from the inoculation with the test bacterial solution, and the leaves inoculated with the test bacterial solution are photographed 4 days later.

[0094] See photos Figure 3Leaves inoculated with EtHAn-AopP2 bacterial solution developed water-soaked necrotic spots. Leaves inoculated with EtHAn-EV bacterial solution did not develop water-soaked necrotic spots.

[0095] 2. Detect ROS

[0096] Timing began 15 hours after inoculation with the test bacterial culture. Leaf samples were collected using a 4mm diameter circular punch to create circular leaf samples, termed leaf discs. In a white 96-well plate, 10μL of deionized water was added to each well, followed by one leaf disc, and then 100μL of L-012 working solution. The plate was then analyzed using a microplate reader with a luminescent module for 120 minutes, and statistical data were collected.

[0097] L-012 working solution: Weigh 0.0209g MOPS into 10mL of deionized water, then add KOH until the pH is 7.4, and then add 0.0016g L-012 chemiluminescent probe (WAKO and Guangchun Pharmaceutical products). MOPS, full name 3-(N-morpholino)propanesulfonic acid, CAS number 1132-61-2, is a product of Shanghai Yuanye Biotechnology Co., Ltd.

[0098] See results Figure 4 (Sample size N = 12). Compared with the EtHAn-EV inoculated group, the ROS burst in the EtHAn-AopP2 inoculated group was suppressed.

[0099] 3. Statistical conductivity

[0100] Starting from the inoculation of the test bacterial solution, after 96 hours, the leaves inoculated with the test bacterial solution were collected. A circular perforator with a diameter of 1 cm was used to punch holes to obtain a 1 cm diameter circular leaf sample, referred to as a leaf disc. One leaf disc was added to each 5 mL centrifuge tube, followed by 4 mL of deionized water. The tubes were incubated at 37℃ and 220 rpm with shaking for 4 hours. The conductivity was then measured and recorded.

[0101] See results Figure 5 (Sample size N=6). Compared with the EtHAn-EV inoculated group, the conductivity of the EtHAn-AopP2 inoculated group was significantly increased.

[0102] Example 3: AopP2 protein inhibits MAPK pathway expression

[0103] Test bacterial suspension: EtHAn-AopP2 or EtHAn-EV bacterial suspension prepared in step one of Example 2.

[0104] Seedlings of Jingxin No. 4 watermelon were cultured normally until they had only two cotyledons, and then inoculated with the test bacterial solution. Inoculation method: Each cotyledon was injected separately on both sides of the main vein, so that the leaf was filled with the test bacterial solution.

[0105] Timing began at 0:00, 4 hours, and 8 hours after inoculation with the tested bacterial culture. Leaves were harvested, rapidly frozen in liquid nitrogen, and total protein was extracted before Western bolus analysis. The primary antibody used for Western bolus analysis was phospho-p44 / 42 antibody (Cell Signaling Technology; 1:1000), and the secondary antibody was goat anti-rabbit IgG HRP (Abmart; 1:5000). Protein images were captured using a Tanon-5200 imaging system.

[0106] See results Figure 6 Compared with the EtHAn-EV inoculated group, the MAPK pathway expression was inhibited in the EtHAn-AopP2 inoculated group.

[0107] Example 4: AopP2 protein positively regulates watermelon resistance to bacterial fruit spot disease.

[0108] I. Preparation of Antibacterial Bacterial Solution

[0109] The recombinant strain EtHAn-AopP2 was inoculated into liquid KB medium containing 100 μg / mL ampicillin and 50 μg / mL gentamicin, and cultured at 28°C with shaking at 200 rpm until OD. 600nm The value was 2.0, and then 10 mmol / L MgCl2 aqueous solution was added to obtain a bacterial concentration of 5 × 10⁻⁶. 6 A bacterial solution with cfu / mL is called bacterial solution EtHAn-AopP2.

[0110] The recombinant strain EtHAn-EV was inoculated into liquid KB medium containing 100 μg / mL ampicillin and 50 μg / mL gentamicin, and cultured at 28°C with shaking at 200 rpm until OD. 600nm The value was 2.0, and then 10 mmol / L MgCl2 aqueous solution was added to obtain a bacterial concentration of 5 × 10⁻⁶. 6 A bacterial culture with cfu / mL is called EtHAn-EV.

[0111] II. Preparation of pathogenic bacteria inoculum

[0112] The watermelon acidophilus AAC00-1, whose full name is Paracidovorax citrulli AAC00-1, has the NCBI number GCA_000015325.1 (RefSeq: GCF_000015325.1).

[0113] The pBBR1MCS-2 plasmid was introduced into watermelon acidophilic bacteria AAC00-1 to obtain recombinant bacteria AAC00-1-pBBR1MCS2.

[0114] The recombinant strain AAC00-1-pBBR1MCS2 was inoculated into liquid KB medium containing 100 μg / mL ampicillin and 50 μg / mL kanamycin, and cultured at 28°C with shaking at 200 rpm until OD. 600nm The value was 2.0, and then 10 mmol / L MgCl2 aqueous solution was added to obtain a bacterial concentration of 2 × 10⁻⁶. 8 A bacterial suspension with a concentration of cfu / mL is considered a pathogenic bacterial suspension.

[0115] III. Disease Resistance Testing

[0116] Test bacterial suspension: bacterial suspension EtHAn-AopP2 or bacterial suspension EtHAn-EV prepared in step one.

[0117] Watermelon seedlings of the Jingxin 4 variety were cultured normally until they had only two cotyledons, then inoculated with the test bacterial solution, followed by inoculation with the pathogenic bacterial solution 24 hours later. Normal culture was then continued.

[0118] Inoculation method of the test bacterial solution: Inject the test bacterial solution into each cotyledon on both sides of the main vein, so that the leaf is filled with the test bacterial solution.

[0119] Inoculation method for pathogenic bacteria solution: Spray the entire plant with about 20 mL of pathogenic bacteria solution per plant.

[0120] Timing began from the start of inoculation with the pathogenic bacterial solution. Inoculated leaves were harvested and photographed at 2, 4, and 6 days post-inoculation. (Photos are available in the attached image.) Figure 7 .

[0121] Timing began from the start of inoculation with the pathogenic bacterial suspension. Inoculated leaves were harvested 2 and 4 days later. Each leaf was sampled by punching holes in a circular sampler with a diameter of 1 cm, resulting in a 1 cm circular leaf sample, termed a leaf disc. Six leaf discs were added to each 2 mL centrifuge tube, followed by 1 mL of deionized water. The leaves were then crushed and serially diluted 10-fold with sterile deionized water to obtain various dilutions. 10 μL of each dilution was inoculated onto KB agar plates containing 100 μg / mL ampicillin and 100 μg / mL kanamycin (six agar plates were used as biological replicates for each dilution). The plates were incubated at 28°C for 48 h, and the number of pathogenic bacterial colonies was counted. The number of pathogenic bacterial colonies per square centimeter of leaf disc was calculated, and the results are shown below. Figure 8 (Sample size N = 6).

[0122] The results showed that the disease resistance of the group inoculated with EtHAn-EV was increased compared with that of the group inoculated with EtHAn-AopP2.

[0123] The present invention has been described in detail above. For those skilled in the art, the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. Although specific embodiments have been given, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein. Some of the essential features can be applied within the scope of the following appended claims.

Claims

1. A method for cultivating plants with enhanced disease resistance and / or antibacterial activity, comprising the following steps: introducing a recombinant microorganism containing a nucleic acid molecule encoding an AopP2 protein into a recipient plant to obtain a plant with enhanced disease resistance and / or antibacterial activity; wherein the AopP2 protein is the protein shown in SEQ ID NO: 1; The recombinant microorganism is a recombinant bacterium obtained by introducing a recombinant vector containing a nucleic acid molecule encoding the AopP2 protein into *Pseudomonas fluorescens* EtHAn. The recombinant microorganisms were cultured in a bacterial suspension and injected into each cotyledon of a plant seedling with only two cotyledons. The injection was performed on both sides of the main vein, ensuring the leaf was completely filled with the bacterial suspension. The concentration of the recombinant bacteria in the bacterial suspension was 5 × 10⁻⁶. 6 cfu / mL; The disease resistance refers to resistance to bacterial fruit spot disease; the antibacterial property refers to resistance to watermelon acidophilus; and the plant is watermelon.

2. The method as described in claim 1, characterized in that: The coding region of the nucleic acid molecule encoding the AopP2 protein is shown as positions 1 to 1515 in SEQ ID NO: 2.